ArticleSaudi medical journal2016
Depression and anxiety in patients with hematological malignancies, prevalence, and associated factors.
Article in Saudi medical journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- The impact of anxiety and depression on hematologic malignancy outcomes: a systematic review and meta-analysis.BMC cancer · 2025Pooled it
- The prevalence of anxiety symptoms/disorders in cancer patients: a meta-analysis.Frontiers in psychiatry · 2024Pooled it
- A systematic review of coping skill interventions to reduce anxiety and depressive symptoms among adults with hematologic malignancies.European journal of oncology nursing : the official journal of European Oncology Nursing Society · 2022Pooled it
- Imatinib-Induced Changes in Anxiety-Like Behaviors are Associated With Prefrontal Cortical Metabolic Remodeling in Mice.Alpha psychiatry · 2026Article
- A latent profile analysis of financial toxicity and its association with anxiety and depression in patients with hematologic malignancies.Asia-Pacific journal of oncology nursing · 2025Article
- The protective role of HCWs communication for the distress of newly diagnosed people with leukemia and lymphoma.PEC innovation · 2025Article
- Article
- Psychometric Properties of the Depression Anxiety Stress Scales (DASS-42 and DASS-21) in Patients with Hematologic Malignancies.Journal of clinical medicine · 2025Article
- The prevalence of depression and anxiety symptoms and their associated factors among patients with cancer in Qatar: A cross-sectional study.Qatar medical journal · 2025Article
- A chain mediation model reveals the association between metacognition and quality of life in hematologic tumor patients.Scientific reports · 2024Article
- Examining the levels of psychological support available to patients with haematological cancer in England: a mixed methods study.BMJ open · 2023Article
- A Comparison of Two Scales to Determine Prevalence of Mood Disorders in Omani Patients Recently Diagnosed with Cancer.Asian Pacific journal of cancer prevention : APJCP · 2022Article
- Article
- Predicting anxiety in cancer survivors presenting to primary care - A machine learning approach accounting for physical comorbidity.Cancer medicine · 2021Article
- Quality of life and distress assessed with self and external assessment screening tools in patients with hematologic malignancies attending treatment in an acute hospital.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2020Article
- Pre-transplant depression decreased overall survival of patients receiving allogeneic hematopoietic stem cell transplantation: a nationwide cohort study.Scientific reports · 2020Article
- Adapted physical activity and hematological malignancies.The Pan African medical journal · 2020Article
- Article
- Prevalence and Associated Factors of Depressive Symptoms in Patients with Myasthenia Gravis: A Cross-Sectional Study of Two Tertiary Hospitals in Riyadh, Saudi Arabia.Behavioural neurology · 2019Article
- Global, regional, and national prevalence of depression among cancer patients: A systematic review and meta-analysis.Indian journal of psychiatryArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo study the prevalence and associated factors of depression and anxiety in hematological cancers (HC) patients.
methodsWe conducted a cross-sectional survey in all HC patients at King Abdulaziz Medical City (KAMC), Riyadh, Saudi Arabia between March 2014 and June 2015. We excluded patients with depression, or generalized anxiety disorder. We conducted a structured face to face interview using an internally developed and validated questionnaire (Patient Health Questionnaire-9 and Generalized Anxiety Disorder-7 patient's questionnaire with all participants).
resultsAmong 211 participants, depression was detected in 98 (46.5%) and anxiety was detected in 47 (22.3%). Thirty-eight (18.1%) had concurrent anxiety and depression. Multiple co-morbidities and tense home atmosphere were predictive for anxiety and depression. We found no association between gender, smoking, income, or being on active therapy and depression or anxiety.
conclusionsDepression and anxiety are highly prevalent in HC patients in KAMC. Health care providers should screen HC cancers for depression and anxiety; as early intervention possibly improve their disease outcome and will likely enhance their psychological wellbeing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.